| CORT |
Corcept Therapeutics Incorporated |
5.86B |
4.40% |
|
|
|
|
|
55.92 |
-0.30% |
67.93% |
30.36% |
|---|
| LBPH |
Longboard Pharmaceuticals, Inc. |
2.33B |
4.12% |
|
|
|
|
|
59.77 |
0.00% |
40.30% |
-0.13% |
|---|
| BMY |
Bristol-Myers Squibb Company |
118.10B |
3.67% |
|
|
|
|
|
58.23 |
0.60% |
23.40% |
18.97% |
|---|
| EWTX |
Edgewise Therapeutics, Inc. |
3.03B |
3.59% |
|
|
|
|
|
31.98 |
0.09% |
106.95% |
26.95% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
7.56B |
3.54% |
|
|
|
|
|
125.10 |
4.91% |
45.21% |
40.60% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
9.06B |
3.50% |
|
|
|
|
|
85.45 |
-0.22% |
32.01% |
9.86% |
|---|
| VTRS |
Viatris Inc. |
15.82B |
3.47% |
|
|
|
|
|
13.25 |
0.91% |
32.48% |
9.75% |
|---|
| CTLT |
Catalent, Inc. |
10.83B |
3.40% |
|
|
|
|
|
59.66 |
1.12% |
42.64% |
36.94% |
|---|
| PFE |
Pfizer Inc. |
142.41B |
3.39% |
|
|
|
|
|
25.13 |
0.76% |
29.73% |
67.95% |
|---|
| RPRX |
Royalty Pharma plc |
11.73B |
3.38% |
|
|
|
|
|
26.40 |
0.69% |
25.03% |
54.58% |
|---|
| JNJ |
Johnson & Johnson |
374.38B |
3.37% |
|
|
|
|
|
155.50 |
1.56% |
18.20% |
30.35% |
|---|
| LLY |
Eli Lilly and Company |
711.91B |
3.35% |
|
|
|
|
|
749.92 |
-0.46% |
39.04% |
42.37% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
4.76B |
3.31% |
|
|
|
|
|
98.19 |
3.79% |
78.65% |
76.91% |
|---|
| ZTS |
Zoetis Inc. |
79.73B |
3.28% |
|
|
|
|
|
176.71 |
0.59% |
22.61% |
7.97% |
|---|
| PRGO |
Perrigo Company plc |
3.69B |
3.17% |
|
|
|
|
|
27.08 |
-0.26% |
38.73% |
31.78% |
|---|
| MRK |
Merck & Co., Inc. |
252.61B |
3.10% |
|
|
|
|
|
99.86 |
2.48% |
24.01% |
49.79% |
|---|
| ELAN |
Elanco Animal Health Incorporated |
6.62B |
2.97% |
|
|
|
|
|
13.40 |
-0.30% |
37.96% |
19.30% |
|---|
| OGN |
Organon & Co. |
3.83B |
2.93% |
|
|
|
|
|
14.89 |
1.09% |
44.42% |
47.52% |
|---|
| ARVN |
Arvinas, Inc. |
1.73B |
2.74% |
|
|
|
|
|
25.11 |
10.67% |
87.17% |
42.12% |
|---|
| SAVA |
Cassava Sciences, Inc. |
1.55B |
2.60% |
|
|
|
|
|
32.18 |
23.53% |
456.46% |
100.92% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
1.77B |
2.37% |
|
|
|
|
|
46.40 |
-0.39% |
97.83% |
71.53% |
|---|
| AMPH |
Amphastar Pharmaceuticals, Inc. |
2.14B |
2.32% |
|
|
|
|
|
44.55 |
1.04% |
73.30% |
55.72% |
|---|
| PBH |
Prestige Consumer Healthcare Inc. |
4.16B |
2.20% |
|
|
|
|
|
84.14 |
1.78% |
39.97% |
29.36% |
|---|
| SUPN |
Supernus Pharmaceuticals, Inc. |
1.98B |
2.04% |
|
|
|
|
|
35.82 |
-0.83% |
28.61% |
32.26% |
|---|
| PCRX |
Pacira BioSciences, Inc. |
802.49M |
2.02% |
|
|
|
|
|
17.38 |
2.06% |
58.40% |
16.78% |
|---|
| COLL |
Collegium Pharmaceutical, Inc. |
980.73M |
1.75% |
|
|
|
|
|
30.41 |
1.37% |
64.99% |
64.91% |
|---|
| LGND |
Ligand Pharmaceuticals Incorporated |
2.20B |
1.73% |
|
|
|
|
|
116.55 |
4.47% |
47.98% |
35.94% |
|---|
| OCUL |
Ocular Therapeutix, Inc. |
1.34B |
1.64% |
|
|
|
|
|
8.52 |
-2.96% |
84.68% |
32.89% |
|---|
| ANIP |
ANI Pharmaceuticals, Inc. |
1.17B |
1.55% |
|
|
|
|
|
55.86 |
1.38% |
38.75% |
50.47% |
|---|
| HRMY |
Harmony Biosciences Holdings, Inc. |
1.90B |
1.32% |
|
|
|
|
|
33.23 |
1.34% |
60.46% |
53.06% |
|---|
| HROW |
Harrow Health, Inc. |
1.56B |
1.28% |
|
|
|
|
|
43.88 |
3.39% |
62.17% |
14.42% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
3.84B |
1.26% |
|
|
|
|
|
8.32 |
-1.07% |
141.67% |
48.35% |
|---|
| WVE |
Wave Life Sciences Ltd. |
2.19B |
1.16% |
|
|
|
|
|
14.35 |
0.63% |
72.55% |
1.80% |
|---|
| EYPT |
EyePoint Pharmaceuticals, Inc. |
569.90M |
1.15% |
|
|
|
|
|
8.35 |
-6.76% |
74.74% |
11.70% |
|---|
| INVA |
Innoviva, Inc. |
1.19B |
1.02% |
|
|
|
|
|
19.06 |
-0.47% |
94.26% |
51.89% |
|---|
| PLRX |
Pliant Therapeutics, Inc. |
781.97M |
1.01% |
|
|
|
|
|
12.85 |
0.94% |
130.50% |
33.14% |
|---|
| LQDA |
Liquidia Corporation |
859.06M |
0.98% |
|
|
|
|
|
10.15 |
0.30% |
70.37% |
6.41% |
|---|
| MNMD |
Mind Medicine (MindMed) Inc. |
519.92M |
0.95% |
|
|
|
|
|
7.09 |
-5.72% |
93.66% |
33.23% |
|---|
| PHAT |
Phathom Pharmaceuticals, Inc. |
646.17M |
0.90% |
|
|
|
|
|
9.45 |
8.25% |
103.85% |
44.25% |
|---|
| FULC |
Fulcrum Therapeutics, Inc. |
160.20M |
0.84% |
|
|
|
|
|
2.9700 |
-0.67% |
107.86% |
49.43% |
|---|
| NMRA |
Neumora Therapeutics, Inc. Common Stock |
1.55B |
0.82% |
|
|
|
|
|
9.69 |
-1.02% |
178.81% |
52.96% |
|---|
| EOLS |
Evolus, Inc. |
825.71M |
0.73% |
|
|
|
|
|
13.04 |
3.25% |
56.93% |
76.49% |
|---|
| ELVN |
Enliven Therapeutics, Inc. |
1.24B |
0.72% |
|
|
|
|
|
25.41 |
-0.08% |
37.20% |
16.05% |
|---|
| XERS |
Xeris Biopharma Holdings, Inc. |
453.21M |
0.49% |
|
|
|
|
|
3.04 |
-0.65% |
158.88% |
43.55% |
|---|
| NUVB |
Nuvation Bio Inc. |
908.73M |
0.48% |
|
|
|
|
|
2.7000 |
4.65% |
247.74% |
12.42% |
|---|
|
SSI US GOV MONEY MARKET CLASS |
|
N/A |
|
|
|
|
|
|
|
|
|
|---|